- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
3
0 new
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3 companies
AFT Pharmaceuticals
Market Cap: NZ$298.9m
Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.85
7D
2.5%
1Y
-8.1%
BLIS Technologies
Market Cap: NZ$20.5m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.016
7D
-5.9%
1Y
-5.9%
Pacific Edge
Market Cap: NZ$66.6m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.082
7D
0%
1Y
-19.6%